An Open-label, Single-dose Clinical Study to Evaluate Oral Mucosa Absorption of IN-C004 in Healthy Volunteers
Latest Information Update: 01 Feb 2021
At a glance
- Drugs IN-C004 (Primary)
- Indications Gastro-oesophageal reflux
- Focus Pharmacokinetics
- Sponsors HK inno.N
- 27 Jan 2021 Status changed from not yet recruiting to completed.
- 10 Dec 2020 New trial record